These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 34029566)
1. Emphysema Progression and Lung Function Decline Among Angiotensin Converting Enzyme Inhibitors and Angiotensin-Receptor Blockade Users in the COPDGene Cohort. Tejwani V; Fawzy A; Putcha N; Castaldi PJ; Cho MH; Pratte KA; Bhatt SP; Lynch DA; Humphries SM; Kinney GL; D'Alessio FR; Hansel NN; Chest; 2021 Oct; 160(4):1245-1254. PubMed ID: 34029566 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin-Converting Inhibitors and Angiotensin II Receptor Blockers and Longitudinal Change in Percent Emphysema on Computed Tomography. The Multi-Ethnic Study of Atherosclerosis Lung Study. Parikh MA; Aaron CP; Hoffman EA; Schwartz JE; Madrigano J; Austin JHM; Kalhan R; Lovasi G; Watson K; Stukovsky KH; Barr RG Ann Am Thorac Soc; 2017 May; 14(5):649-658. PubMed ID: 28207279 [TBL] [Abstract][Full Text] [Related]
3. Five-year Progression of Emphysema and Air Trapping at CT in Smokers with and Those without Chronic Obstructive Pulmonary Disease: Results from the COPDGene Study. Pompe E; Strand M; van Rikxoort EM; Hoffman EA; Barr RG; Charbonnier JP; Humphries S; Han MK; Hokanson JE; Make BJ; Regan EA; Silverman EK; Crapo JD; Lynch DA; Radiology; 2020 Apr; 295(1):218-226. PubMed ID: 32013794 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary Arterial Pruning and Longitudinal Change in Percent Emphysema and Lung Function: The Genetic Epidemiology of COPD Study. Pistenmaa CL; Nardelli P; Ash SY; Come CE; Diaz AA; Rahaghi FN; Barr RG; Young KA; Kinney GL; Simmons JP; Wade RC; Wells JM; Hokanson JE; Washko GR; San José Estépar R; Chest; 2021 Aug; 160(2):470-480. PubMed ID: 33607083 [TBL] [Abstract][Full Text] [Related]
5. Ratio of FEV Fortis S; Comellas AP; Bhatt SP; Hoffman EA; Han MK; Bhakta NR; Paine R; Ronish B; Kanner RE; Dransfield M; Hoesterey D; Buhr RG; Barr RG; Dolezal B; Ortega VE; Drummond MB; Arjomandi M; Kaner RJ; Kim V; Curtis JL; Bowler RP; Martinez F; Labaki WW; Cooper CB; O'Neal WK; Criner G; Hansel NN; Krishnan JA; Woodruff P; Couper D; Tashkin D; Barjaktarevic I Chest; 2021 Jul; 160(1):94-103. PubMed ID: 33539837 [TBL] [Abstract][Full Text] [Related]
6. Fleischner Society Visual Emphysema CT Patterns Help Predict Progression of Emphysema in Current and Former Smokers: Results from the COPDGene Study. El Kaddouri B; Strand MJ; Baraghoshi D; Humphries SM; Charbonnier JP; van Rikxoort EM; Lynch DA Radiology; 2021 Feb; 298(2):441-449. PubMed ID: 33320065 [TBL] [Abstract][Full Text] [Related]
7. Contribution of CT quantified emphysema, air trapping and airway wall thickness on pulmonary function in male smokers with and without COPD. Mohamed Hoesein FA; de Jong PA; Lammers JW; Mali WP; Mets OM; Schmidt M; de Koning HJ; Aalst Cv; Oudkerk M; Vliegenthart R; Ginneken Bv; van Rikxoort EM; Zanen P COPD; 2014 Sep; 11(5):503-9. PubMed ID: 25093696 [TBL] [Abstract][Full Text] [Related]
8. Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease. Schroeder JD; McKenzie AS; Zach JA; Wilson CG; Curran-Everett D; Stinson DS; Newell JD; Lynch DA AJR Am J Roentgenol; 2013 Sep; 201(3):W460-70. PubMed ID: 23971478 [TBL] [Abstract][Full Text] [Related]
9. CT Chest Imaging Using Normalized Join-Count: Predicting Emphysema Progression in the CanCOLD Study. Virdee S; Tan WC; Hogg JC; Bourbeau J; Hague CJ; Kirby M; Radiology; 2024 Jul; 312(1):e233265. PubMed ID: 39012250 [TBL] [Abstract][Full Text] [Related]
10. Impact of gastroesophageal reflux on longitudinal lung function and quantitative computed tomography in the COPDGene cohort. Baldomero AK; Wendt CH; Petersen A; Gaeckle NT; Han MK; Kunisaki KM; Respir Res; 2020 Aug; 21(1):203. PubMed ID: 32746820 [TBL] [Abstract][Full Text] [Related]
11. Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS. Arjomandi M; Zeng S; Barjaktarevic I; Barr RG; Bleecker ER; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Cooper CB; Couper DJ; Curtis JL; Dransfield MT; Han MK; Hansel NN; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Paine R; Peters SP; Rennard SI; Woodruff PG; Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31439683 [TBL] [Abstract][Full Text] [Related]
12. Computed tomography-quantified emphysema distribution is associated with lung function decline. Mohamed Hoesein FA; van Rikxoort E; van Ginneken B; de Jong PA; Prokop M; Lammers JW; Zanen P Eur Respir J; 2012 Oct; 40(4):844-50. PubMed ID: 22323577 [TBL] [Abstract][Full Text] [Related]
13. Visual Emphysema at Chest CT in GOLD Stage 0 Cigarette Smokers Predicts Disease Progression: Results from the COPDGene Study. Oh AS; Strand M; Pratte K; Regan EA; Humphries S; Crapo JD; Lynch DA; Radiology; 2020 Sep; 296(3):641-649. PubMed ID: 32633676 [TBL] [Abstract][Full Text] [Related]
14. Relationship between Emphysema Progression at CT and Mortality in Ever-Smokers: Results from the COPDGene and ECLIPSE Cohorts. Ash SY; San José Estépar R; Fain SB; Tal-Singer R; Stockley RA; Nordenmark LH; Rennard S; Han MK; Merrill D; Humphries SM; Diaz AA; Mason SE; Rahaghi FN; Pistenmaa CL; Sciurba FC; Vegas-Sánchez-Ferrero G; Lynch DA; Washko GR; Radiology; 2021 Apr; 299(1):222-231. PubMed ID: 33591891 [TBL] [Abstract][Full Text] [Related]
15. Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study. Kirby M; Tanabe N; Tan WC; Zhou G; Obeidat M; Hague CJ; Leipsic J; Bourbeau J; Sin DD; Hogg JC; Coxson HO; ; ; Am J Respir Crit Care Med; 2018 Jan; 197(1):56-65. PubMed ID: 28886252 [TBL] [Abstract][Full Text] [Related]
16. The Peak Index: Spirometry Metric for Airflow Obstruction Severity and Heterogeneity. Bhatt SP; Bodduluri S; Raghav V; Bhakta NR; Wilson CG; Kim YI; Eberlein M; Sciurba FC; Han MK; Dransfield MT; Nakhmani A Ann Am Thorac Soc; 2019 Aug; 16(8):982-989. PubMed ID: 30865842 [No Abstract] [Full Text] [Related]
17. Quantitative CT Evaluation of Emphysema Progression over 10 Years in the COPDGene Study. Baraghoshi D; Strand M; Humphries SM; San José Estépar R; Vegas Sanchez-Ferrero G; Charbonnier JP; Latisenko R; Silverman EK; Crapo JD; Lynch DA Radiology; 2023 May; 307(4):e222786. PubMed ID: 37039685 [TBL] [Abstract][Full Text] [Related]
18. CT-quantified emphysema in male heavy smokers: association with lung function decline. Mohamed Hoesein FA; de Hoop B; Zanen P; Gietema H; Kruitwagen CL; van Ginneken B; Isgum I; Mol C; van Klaveren RJ; Dijkstra AE; Groen HJ; Boezen HM; Postma DS; Prokop M; Lammers JW Thorax; 2011 Sep; 66(9):782-7. PubMed ID: 21474499 [TBL] [Abstract][Full Text] [Related]
19. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD. Pratte KA; Curtis JL; Kechris K; Couper D; Cho MH; Silverman EK; DeMeo DL; Sciurba FC; Zhang Y; Ortega VE; O'Neal WK; Gillenwater LA; Lynch DA; Hoffman EA; Newell JD; Comellas AP; Castaldi PJ; Miller BE; Pouwels SD; Hacken NHTT; Bischoff R; Klont F; Woodruff PG; Paine R; Barr RG; Hoidal J; Doerschuk CM; Charbonnier JP; Sung R; Locantore N; Yonchuk JG; Jacobson S; Tal-Singer R; Merrill D; Bowler RP Respir Res; 2021 Apr; 22(1):127. PubMed ID: 33906653 [TBL] [Abstract][Full Text] [Related]
20. Disproportionate contribution of right middle lobe to emphysema and gas trapping on computed tomography. Bhatt SP; Sieren JC; Newell JD; Comellas AP; Hoffman EA PLoS One; 2014; 9(7):e102807. PubMed ID: 25054539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]